Clinical Trial Update: Extension to Study HMR1964A/3011 in Belgium [Phase 4]

View source ↗

Summary

Sanofi announced an extension of the Phase 4 trial HMR1964A/3011 in Belgium for diabetes mellitus, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• HMR1964A/3011

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED